Literature DB >> 20425619

The quality-of-life impact of prostate cancer treatments.

Jaspreet Singh1, Edouard J Trabulsi, Leonard G Gomella.   

Abstract

Many options exist for the treatment of localized prostate cancer. In the decision to choose a therapeutic option for localized disease, many variables need to be considered such as tumor characteristics, clinical stage, the patient's overall health and life expectancy, and preferences of both the physician and patient. Another important consideration is the health-related quality of life (HRQOL) implications of a given treatment option. The importance of HRQOL relative to the potential side effects of prostate cancer treatments has grown over the past few years. Although our collective awareness has increased, objective data on HRQOL for prostate cancer treatment are lacking due to a paucity of prospective clinical trial data. This review defines the concept of HRQOL, discusses what is currently known about the impact of various treatments on HRQOL, and summarizes the recent literature in this area relating to the management of localized prostate cancer.

Entities:  

Mesh：

Year:  2010        PMID： 20425619     DOI： 10.1007/s11934-010-0103-y

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN： 1527-2737            Impact factor:   3.092


  31 in total

1.  Health perceptions in patients who undergo screening and workup for prostate cancer.

Authors:  David A Katz; David F Jarrard; Colleen A McHorney; Stephen L Hillis; Donald A Wiebe; Dennis G Fryback
Journal:  Urology       Date:  2007-02       Impact factor: 2.649

2.  Nerve-sparing surgery significantly affects long-term continence after radical prostatectomy.

Authors:  Kalyana C Nandipati; Rupesh Raina; Ashok Agarwal; Craig D Zippe
Journal:  Urology       Date:  2007-12       Impact factor: 2.649

3.  Fear of recurrence, symptom burden, and health-related quality of life in men with prostate cancer.

Authors:  Keith M Bellizzi; David M Latini; Janet E Cowan; Janeen DuChane; Peter R Carroll
Journal:  Urology       Date:  2008-03-17       Impact factor: 2.649

4.  Factors associated with prostate cancer patients' and their spouses' satisfaction with a family-based intervention.

Authors:  Janet Harden; Margaret Falahee; Joan Bickes; Ann Schafenacker; Julie Walker; Darlene Mood; Laurel Northouse
Journal:  Cancer Nurs       Date:  2009 Nov-Dec       Impact factor: 2.592

5.  Impact of cancer on health-related quality of life of older Americans.

Authors:  Bryce B Reeve; Arnold L Potosky; Ashley Wilder Smith; Paul K Han; Ron D Hays; William W Davis; Neeraj K Arora; Samuel C Haffer; Steven B Clauser
Journal:  J Natl Cancer Inst       Date:  2009-06-09       Impact factor: 13.506

6.  Anxiety associated with prostate cancer screening with special reference to men with a positive screening test (elevated PSA) - Results from a prospective, population-based, randomised study.

Authors:  Sigrid Carlsson; Gunnar Aus; Catrin Wessman; Jonas Hugosson
Journal:  Eur J Cancer       Date:  2007-07-23       Impact factor: 9.162

Review 7.  Low risk prostate cancer in men under age 65: the case for definitive treatment.

Authors:  Thomas L Jang; Ofer Yossepowitch; Fernando J Bianco; Peter T Scardino
Journal:  Urol Oncol       Date:  2007 Nov-Dec       Impact factor: 3.498

Review 8.  Robotic-assisted radical prostatectomy: a review of current outcomes.

Authors:  Rafael F Coelho; Sanket Chauhan; Kenneth J Palmer; Bernardo Rocco; Manoj B Patel; Vipul R Patel
Journal:  BJU Int       Date:  2009-10-05       Impact factor: 5.588

9.  Population-based prostate-specific antigen testing in the UK leads to a stage migration of prostate cancer.

Authors:  Alison L Moore; Polyxeni Dimitropoulou; Athene Lane; Philip H Powell; David C Greenberg; Clement H Brown; Jenny L Donovan; Freddie C Hamdy; Richard M Martin; David E Neal
Journal:  BJU Int       Date:  2009-06-19       Impact factor: 5.588

10.  The prognostic association of health-related quality of life scores with survival in breast cancer.

Authors:  Digant Gupta; Joel Granick; James F Grutsch; Christopher G Lis
Journal:  Support Care Cancer       Date:  2006-11-09       Impact factor: 3.359
View more
  12 in total

1.  Ganoderic Acid DM: An Alternative Agent for the Treatment of Advanced Prostate Cancer.

Authors:  Benjamin M Johnson; Bently P Doonan; Faisal F Radwan; Azizul Haque
Journal:  Open Prost Cancer J       Date:  2010-01-01

Review 2.  The effect of ethnicity and sexual preference on prostate-cancer-related quality of life.

Authors:  Nir Kleinmann; Nicholas G Zaorsky; Timothy N Showalter; Leonard G Gomella; Costas D Lallas; Edouard J Trabulsi
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

Review 3.  Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials.

Authors:  Bryce B Reeve; Sandra A Mitchell; Amylou C Dueck; Ethan Basch; David Cella; Carolyn Miller Reilly; Lori M Minasian; Andrea M Denicoff; Ann M O'Mara; Michael J Fisch; Cynthia Chauhan; Neil K Aaronson; Corneel Coens; Deborah Watkins Bruner
Journal:  J Natl Cancer Inst       Date:  2014-07-08       Impact factor: 13.506

4.  Endoplasmic reticulum stress, autophagic and apoptotic cell death, and immune activation by a natural triterpenoid in human prostate cancer cells.

Authors:  Benjamin M Johnson; Faisal F Y Radwan; Azim Hossain; Bently P Doonan; Jessica D Hathaway-Schrader; Jason M God; Christina V Voelkel-Johnson; Narendra L Banik; Sakamuri V Reddy; Azizul Haque
Journal:  J Cell Biochem       Date:  2018-10-30       Impact factor: 4.429

5.  Quality of life, religious attitude and cancer coping in a sample of Iranian patients with cancer.

Authors:  Mohammad-Kazem Atef-Vahid; Mehdi Nasr-Esfahani; Mohsen Saberi Esfeedvajani; Homayoon Naji-Isfahani; Mohammad Reza Shojaei; Yasavoli M Masoumeh; S Ashrafodin Goushegir
Journal:  J Res Med Sci       Date:  2011-07       Impact factor: 1.852

Review 6.  Achieving optimal delivery of follow-up care for prostate cancer survivors: improving patient outcomes.

Authors:  Shawna V Hudson; Denalee M O'Malley; Suzanne M Miller
Journal:  Patient Relat Outcome Meas       Date:  2015-03-19

Review 7.  Patient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision making.

Authors:  Fabio Efficace; Michael Feuerstein; Peter Fayers; Valentina Cafaro; James Eastham; Andrea Pusic; Jane Blazeby
Journal:  Eur Urol       Date:  2013-10-30       Impact factor: 20.096

8.  Application of WHOQOL-BREF in Measuring Quality of Life in Health-Care Staff.

Authors:  Ali Gholami; Leila Moosavi Jahromi; Esmail Zarei; Azizallah Dehghan
Journal:  Int J Prev Med       Date:  2013-07

9.  Fitness outcomes from a randomised controlled trial of exercise training for men with prostate cancer: the ENGAGE study.

Authors:  Cadeyrn J Gaskin; Steve F Fraser; Patrick J Owen; Melinda Craike; Liliana Orellana; Patricia M Livingston
Journal:  J Cancer Surviv       Date:  2016-04-20       Impact factor: 4.442

10.  An Internet-Based Means of Monitoring Quality of Life in Post-Prostate Radiation Treatment: A Prospective Cohort Study.

Authors:  Brent Parker; Rasika Rajapakshe; Andrew Moldovan; Cynthia Araujo; Juanita Crook
Journal:  JMIR Res Protoc       Date:  2015-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.